April 2020

11 Apr 2020 GPN Vaccines awarded $1 million from the South Australian Government

Posted at 09:04h in Announcements

Adelaide, Australia, 11th April 2020 – GPN Vaccines is pleased to announce it has been awarded $1 million from the South Australian Government’s Research, Commercialisation and Startup Fund (RCSF) to support a first in human clinical trial on the Company's broad-spectrum pneumonia vaccine. Established in 2019,...

07 Apr 2020 GPN Vaccines strengthens its clinical development team

Posted at 11:38h in Announcements

Adelaide, Australia, 7 April 2020 – GPN Vaccines is pleased to announce the appointment of Dr Paul Wabnitz as the Company's Medical Director and Mr Jim Ackland as Director, Regulatory & Quality. These two appointments will significantly strengthen the clinical development team in preparation for...

Protecting children and adults from the world’s foremost bacterial pathogen

April 2020

11 Apr 2020 GPN Vaccines awarded $1 million from the South Australian Government

07 Apr 2020 GPN Vaccines strengthens its clinical development team

Meet us at

Follow us on social media

Subscribe Here